Adipose mesenchymal stem cell cryopreservation liquid and application thereof
Through the cryopreservation solution combining components such as human serum albumin, the problem of cytotoxicity and biological activity reduction in fat mesenchymal stem cells is solved, and efficient cell survival rate and exosome secretion ability are achieved, which is of great importance. Industrial application value.
Patent Information
- Application Number
- CN202411193261.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-28
AI Technical Summary
In the existing methods of freezing of fat mesenchymal stem cells, commonly used cryoprotectants have problems of cytotoxicity and biological activity, which leads to a decrease in cell vitality and a weakening of differentiation ability during freezing and thawing. The common storage solution is due to nutritional deficiency. and isotonic changes lead to cell death.
Provide a cryopreservative solution containing human serum albumin, trehalose, poloxamer 188, resveratrol, glutathione, polyvinyl alcohol and DMSO, which is supplemented by compound electrolytes and amino acid injections to form a combination solution. It reaches 100% in a 1:1 ratio to improve cell survival and exosome secretion ability.
It has achieved a cell survival rate of about 98% and a high exosome secretion ability, reducing cell damage during freeze-thawing, maintaining cell activity and regeneration ability, and has important industrial application value.
Smart Images

Figure CN118985590A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to an adipose-derived mesenchymal stem cell cryopreservation solution and application thereof, and belongs to the technical field of cell cryopreservation. Background Art
[0002] Stem cells are a type of multipotent cells with the ability to self-replicate. Under certain conditions, they can differentiate into a variety of functional cells. Mesenchymal stem cells (MSCs) are a member of the stem cell family. They exist in a variety of tissues such as bone marrow, umbilical cord blood and umbilical cord tissue, placental tissue, adipose tissue, etc., and have multidirectional differentiation potential. Among them, adipose mesenchymal stem cells have unique cytokine secretion functions as well as immunomodulatory and anti-inflammatory effects. They are currently used to treat a variety of immune-related diseases. Since adipose mesenchymal stem cells can secrete exosomes, the research on the use of exosomes secreted by mesenchymal cells to prepare a variety of products for biomedicine is also a current hot topic.
[0003] Adipose-derived mesenchymal stem cells have differentiation ability and immunomodulatory properties, and have great potential in the field of regenerative medicine. Cryopreservation, that is, storing cells at ultra-low temperatures, is essential for maintaining the required supply of adipose-derived mesenchymal stem cells. The expanded adipose-derived mesenchymal stem cells need to be frozen to slow down the metabolic activity of the cells and maintain their life in a low-temperature environment, so that they can be used for scientific research and clinical recovery at any time or for convenient transportation and storage.
[0004] At present, cryoprotectants need to be added in the cryopreservation of mesenchymal stem cells. Cryoprotectants can be divided into two categories: permeable and non-permeable, depending on whether they penetrate the cell membrane. Permeable cryoprotectants are generally small molecules, such as glycerol, dimethyl sulfoxide (DMSO), ethylene glycol, propylene glycol, methanol, ethanol, formamide, etc. Their main function is to prevent the formation of ice crystals in cells, avoid the toxicity of high concentrations of cryopreservatives, and dehydrate cells within tolerance; non-permeable cryoprotectants are mainly some macromolecules, such as trehalose, sucrose, glucose, mannitol, sorbitol, hydroxyethyl starch and polyvinyl pyrrolidone.
[0005] The biological activity of mesenchymal stem cells directly affects their cytokine secretion function, immunomodulatory and anti-inflammatory effects, and also affects the secretion efficiency of their exosomes. Therefore, it is a very important technical issue to ensure that mesenchymal stem cells have high biological activity while also meeting the requirements of long-term storage and transportation. At present, the common cryopreservation methods of mesenchymal stem cells mostly use dimethyl sulfoxide, bovine serum, culture medium, etc. mixed in a certain proportion to cryopreserve cells. However, bovine serum is an animal-derived substance and cannot be used in clinical products. DMSO is also toxic to cells and can denature intracellular proteins at room temperature. Cryopreservation with serum may lead to differentiation of stem cells.
[0006] During the freezing process, water in cells forms ice crystals, which pierce the cell membrane and destroy the internal structure, leading to cell death. The removal of water during freezing causes changes in the concentration of solutes in the cell, which generates osmotic pressure, causing cell shrinkage and damage to cell components, resulting in reduced cell viability. Cryoprotectants such as dimethyl sulfoxide, glycerol, ethylene glycol, or propylene glycol can reduce ice crystal formation and protect cell membranes, but they are cytotoxic at high concentrations, so it is crucial to adjust the combination and dosage of each component to balance the cryoprotective effect and reduce cytotoxicity.
[0007] Ordinary saline or glucose solution as a preservation solution for mesenchymal stem cells may cause decreased cell vitality, massive swelling and death, and increased cell agglomeration rate during long-term storage or transportation due to nutrient deficiency, isotonicity or isotonicity of the solution, etc. The preservation solution containing fetal bovine serum or cell culture medium will cause the cells to internalize fetal bovine serum when in contact with it, which will cause changes in the expression characteristics of certain cell proteins. When mesenchymal stem cells are returned to the patient, they may also cause allergic reactions. In addition, freezing and thawing may regulate gene expression and thus affect the ability of MSCs to self-renew and differentiate into special cell types, such as easily leading to the loss or weakening of cell stemness, or causing a decrease in the ability of mesenchymal stem cells to secrete exosomes.
[0008] Therefore, there is an urgent need for an adipose-derived mesenchymal stem cell preservation solution with stable ingredients, diversified nutrients, osmotic pressure close to that of blood, strong buffering capacity, long shelf life and easy transportation, which can maintain the activity of adipose-derived mesenchymal stem cells after freezing and thawing and has efficient exosome secretion ability. Summary of the invention
[0009] In order to solve the above problems, an adipose-derived mesenchymal stem cell cryopreservation solution and its application are provided. The cryopreservation solution provided in the present application can maintain the cell activity of adipose-derived mesenchymal stem cells, and has good regeneration ability after thawing, can maintain a high exosome secretion ability, and has a high expression level of cytokines, and has important industrial application value.
[0010] According to one aspect of the present application, a fat-derived mesenchymal stem cell cryopreservation solution is provided, consisting of the following ingredients: 6-10% v / v human serum albumin solution, 2-4% w / v trehalose, 0.1-0.6% w / v poloxamer 188, 1-2% w / v resveratrol, 1-2% w / v glutathione, 4-6% w / v polyvinyl alcohol and 3-4% v / v DMSO, and finally the compound electrolyte injection and the compound amino acid injection are supplemented to 100% in a 1:1 ratio.
[0011] Optionally, the volume concentration of the human serum albumin solution is 20±5%.
[0012] Optionally, the human serum albumin is recombinant human albumin fermented by Pichia pastoris.
[0013] Optionally, the Pichia pastoris is GS115, KM71, X-33 or SMD1168H or a mutant thereof.
[0014] Optionally, the molecular weight of the polyvinyl alcohol is 12kDa~15kDa. In previous studies, the experimenters found that adding polyvinyl alcohol with a molecular weight of 12kDa~15kDa can significantly improve the cell survival rate after the cryopreserved cells are revived. It is speculated that polyvinyl alcohol with this molecular weight can cooperate with human serum albumin to increase the extracellular osmotic pressure and reduce the free water in the cells, thereby reducing the cell damage caused by ice crystals during the cryopreservation process. In addition, after adding polyvinyl alcohol with a molecular weight of 12kDa~15kDa, the revived cells also have better proliferation ability.
[0015] Optionally, the compound amino acid injection contains L-proline, L-serine, L-alanine, L-isoleucine, L-leucine, L-aspartic acid, L-tyrosine, L-glutamic acid, L-phenylalanine, L-arginine hydrochloride, L-lysine hydrochloride, L-valine, L-threonine, L-histidine hydrochloride, L-tryptophan, L-methionine, L-cystine, glycine, sorbitol and sodium bisulfite.
[0016] Optionally, per 1000 mL of the compound amino acid injection, there is contained 1.00 g of L-proline, 1.00 g of L-serine, 2.00 g of L-alanine, 3.52 g of L-isoleucine, 4.90 g of L-leucine, 2.50 g of L-aspartic acid, 0.25 g of L-tyrosine, 0.75 g of L-glutamic acid, 5.33 g of L-phenylalanine, 5.00 g of L-arginine hydrochloride, 4.30 g of L-lysine hydrochloride, 3.60 g of L-valine, 2.50 g of L-threonine, 2.50 g of L-histidine hydrochloride, 0.90 g of L-tryptophan, 2.25 g of L-methionine, 0.10 g of L-cystine, 7.60 g of glycine, 50.00 g of sorbitol and 0.50 g of sodium bisulfite.
[0017] Optionally, the composite electrolyte solution comprises sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride.
[0018] Optionally, the composite electrolyte solution contains 5.26 g of sodium chloride, 5.02 g of sodium gluconate, 3.68 g of sodium acetate, 0.37 g of potassium chloride and 0.30 g of magnesium chloride per 1000 mL.
[0019] Optionally, it is composed of the following ingredients: human serum albumin solution 8% v / v, trehalose 3% w / v, poloxamer 188 0.4% w / v, resveratrol 1% w / v, glutathione 1% w / v, polyvinyl alcohol 5% w / v and DMSO 3% v / v, and finally the compound electrolyte injection and the compound amino acid injection are supplemented to 100% at a ratio of 1:1.
[0020] According to another aspect of the present application, there is provided a use of any of the above-mentioned adipose-derived mesenchymal stem cell cryopreservation solutions in cryopreservation of adipose-derived mesenchymal stem cells.
[0021] The beneficial effects of this application include but are not limited to: 1. The adipose-derived mesenchymal stem cell cryopreservation solution of the present application can maintain a cell survival rate of about 98% for adipose-derived mesenchymal stem cells. Compared with conventional cryopreservation solutions, it can better protect the internal structure of cells, reduce the change of intracellular solute concentration during freezing and thawing, and has a higher cell survival rate.
[0022] 2. According to the adipose-derived mesenchymal stem cell cryopreservation solution of the present application, the adipose-derived mesenchymal stem cells after cryopreservation have a shorter latent period and a better growth effect in the logarithmic growth phase when proliferating, and still maintain good cell stemness.
[0023] 3. According to the adipose-derived mesenchymal stem cell cryopreservation solution of the present application, the adipose-derived mesenchymal stem cells after thawing and recovery can maintain a high exosome secretion capacity. The cryopreservation solution of the present application not only minimizes the impact of freezing and thawing on adipose-derived mesenchymal stem cells by adjusting the composition and dosage of each component, but also the cryopreservation solution itself has low cytotoxicity to adipose-derived mesenchymal stem cells.
[0024] 4. According to the adipose-derived mesenchymal stem cell cryopreservation solution of the present application, the secretion of TGF-b, HGF, PGE2, and IL-6 cytokines of the thawed adipose-derived mesenchymal stem cells is higher than that of the conventional cryopreservation solution, which shows that the adipose-derived mesenchymal stem cells still maintain a high cytokine secretion capacity and have good cell stemness.
[0025] 5. The adipose-derived mesenchymal stem cell cryopreservation solution of the present application can maintain the cell activity of adipose-derived mesenchymal stem cells, and has good regeneration ability after thawing, can maintain high exosome secretion ability, and has high cytokine expression, and has important industrial application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings: Figure 1This is a growth curve of thawed adipose-derived mesenchymal stem cells involved in Test Example 2 of this application; Figure 2 This is a growth state diagram of adipose-derived mesenchymal stem cells 1d, 2d, 4d and 8d after thawing in Example 1 and Example 4 involved in Test Example 2 of the present application; Figure 3 This is a result diagram of the ability of adipose-derived mesenchymal stem cells to secrete exosomes after thawing involved in Test Example 3 of this application; Figure 4 This is a result diagram of the ability of adipose-derived mesenchymal stem cells to secrete cytokines after thawing involved in Test Example 4 of this application; Figure 5 This is a diagram of the liquid phase detection results of the recombinant human albumin (ART101L-240126-01) involved in Experimental Example 1 of this application. DETAILED DESCRIPTION
[0027] The present application is described in detail below in conjunction with examples, but the present application is not limited to these examples. Unless otherwise specified, the raw materials and catalysts in the examples of the present application are purchased through commercial channels.
[0028] In the present application, hematogenous human serum albumin refers to albumin separated and purified from healthy human blood, plasma or specific immune plasma; recombinant human albumin refers to albumin prepared for treatment and prevention using recombinant DNA technology, for example, the recombinant human albumin used in the present application is prepared using Pichia yeast fermentation.
[0029] In the present application, the compound amino acid injection used comprises L-proline, L-serine, L-alanine, L-isoleucine, L-leucine, L-aspartic acid, L-tyrosine, L-glutamic acid, L-phenylalanine, L-arginine hydrochloride, L-lysine hydrochloride, L-valine, L-threonine, L-histidine hydrochloride, L-tryptophan, L-methionine, L-cystine, glycine, sorbitol and sodium bisulfite; wherein each 1000 mL of the compound amino acid injection contains 1.00 g of L-proline, 1.00 g of L-serine, 2.0 g of L-alanine and 1.00 g of L-glutamic acid. 0g, L-isoleucine 3.52g, L-leucine 4.90g, L-aspartic acid 2.50g, L-tyrosine 0.25g, L-glutamic acid 0.75g, L-phenylalanine 5.33g, L-arginine hydrochloride 5.00g, L-lysine hydrochloride 4.30g, L-valine 3.60g, L-threonine 2.50g, L-histidine hydrochloride 2.50g, L-tryptophan 0.90g, L-methionine 2.25g, L-cystine 0.10g, glycine 7.60g, sorbitol 50.00g and sodium bisulfite 0.5g.
[0030] In the present application, the compound electrolyte solution used comprises sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride; wherein each 1000 mL of the compound electrolyte solution contains 5.26 g of sodium chloride, 5.02 g of sodium gluconate, 3.68 g of sodium acetate, 0.37 g of potassium chloride and 0.3 g of magnesium chloride.
[0031] In this application, MTT and BCA protein concentration determination kits were purchased from Biyuntian Biotechnology Co., Ltd. In this application, Examples 1-3 and Comparative Examples 1-4 use recombinant human albumin solution fermented by Pichia pastoris, with a volume concentration of 20%, which is a self-developed product of the applicant, from Tonghua Anrui Special Biopharmaceutical Co., Ltd., item number ART101L; Example 4 uses a blood-derived human serum albumin solution with a volume concentration of 20%, purchased from Boya Biopharmaceutical Group Co., Ltd. The BI basal culture medium is MSC NutriStem® XF Medium, a Sartorius brand, item number 05-200-1A, which is serum-free, does not contain xenologous animal components, and does not contain antibiotics.
[0032] Example 1 A fat mesenchymal stem cell cryopreservation solution is composed of the following components: 8% v / v recombinant human albumin solution, 3% w / v trehalose, 0.4% w / v poloxamer 188, 1% w / v resveratrol, 1% w / v glutathione, 5% w / v polyvinyl alcohol and 3% v / v DMSO, and finally compound electrolyte injection and compound amino acid injection are supplemented to 100% in a ratio of 1:1; wherein the molecular weight of polyvinyl alcohol is 12 kDa~15 kDa.
[0033] Example 2 A fat mesenchymal stem cell cryopreservation solution is composed of the following components: 6% v / v recombinant human albumin solution, 4% w / v trehalose, 0.1% w / v poloxamer 188, 2% w / v resveratrol, 2% w / v glutathione, 6% w / v polyvinyl alcohol and 3% v / v DMSO, and finally compound electrolyte injection and compound amino acid injection are supplemented to 100% in a ratio of 1:1; wherein the molecular weight of polyvinyl alcohol is 12kDa~15kDa.
[0034] Example 3 A fat mesenchymal stem cell cryopreservation solution is composed of the following components: 10% v / v recombinant human albumin solution, 2% w / v trehalose, 0.6% w / v poloxamer 188, 1% w / v resveratrol, 1% w / v glutathione, 4% w / v polyvinyl alcohol and 4% v / v DMSO, and finally compound electrolyte injection and compound amino acid injection are supplemented to 100% in a ratio of 1:1; wherein the molecular weight of polyvinyl alcohol is 12 kDa~15 kDa.
[0035] Example 4 A fat mesenchymal stem cell cryopreservation solution is composed of the following components: 8% v / v of hematuria human serum albumin solution, 3% w / v of trehalose, 0.4% w / v of poloxamer 188, 1% w / v of resveratrol, 1% w / v of glutathione, 5% w / v of polyvinyl alcohol and 3% v / v of DMSO, and finally compound electrolyte injection and compound amino acid injection are supplemented to 100% in a ratio of 1:1; wherein the molecular weight of polyvinyl alcohol is 12 kDa~15 kDa.
[0036] Comparative Example 1 A fat mesenchymal stem cell cryopreservation solution is composed of the following components: 24% v / v recombinant human albumin solution, 5.7% v / v DMSO, 30.5% v / v compound amino acid injection solution, and finally supplemented to 100% with BI basic culture medium.
[0037] Comparative Example 2 A fat mesenchymal stem cell cryopreservation solution consists of the following components: 40% v / v recombinant human albumin solution, 3% v / v DMSO, 7% v / v glycerol, 25% v / v compound electrolyte injection and 25% v / v dextran.
[0038] Comparative Example 3 A fat mesenchymal stem cell cryopreservation solution is composed of the following ingredients: 10% v / v recombinant human albumin solution, 2% w / v trehalose, 1% w / v glutathione, 4% w / v polyvinyl alcohol and 4% v / v DMSO, and finally compound electrolyte injection and compound amino acid injection are supplemented to 100% in a ratio of 1:1; wherein the molecular weight of polyvinyl alcohol is 12kDa~15kDa.
[0039] Comparative Example 4 A fat mesenchymal stem cell cryopreservation solution is composed of the following components: 10% v / v recombinant human albumin solution, 2% w / v trehalose, 0.6% w / v poloxamer 188, 1% w / v glutathione, and 4% v / v DMSO, and finally compound electrolyte injection and compound amino acid injection are supplemented to 100% in a ratio of 1:1.
[0040] The experimenters conducted experiments and tests on the freezing effects of the cryopreservation solutions in the above Examples 1 to 4 and Comparative Examples 1 to 4 on adipose-derived mesenchymal stem cells, and tested the cell survival rate, cell proliferation ability after thawing, exosome secretion ability, and cytokine expression ability, respectively. The specific detection steps and results are detailed below.
[0041] Test Example 1 Cell Viability Detection Cell cryopreservation process: P5 adipose-derived mesenchymal stem cells (purchased from Wuhan Punosai Life Science Technology Co., Ltd., catalog number CP-H202) were digested with 0.2% trypsin for 4 minutes, and 15 mL of culture medium (composed of BI basal medium and Elite serum replacement, with a volume ratio of 95:5) was added. The cells were gently blown with a pipette to make them uniform, centrifuged at 4000 rpm, the supernatant was discarded, 2 mL of cryopreservation solution was added and mixed, and placed in a sterile cryopreservation tube. The cryopreservation tube was placed in a cooling program instrument for the cooling program. The cooling program is: wait for 30 minutes at 4°C, cool to -7°C at 1°C / min, cool to -40°C at 20°C / min, heat to -18°C at 1°C / min, cool to -50°C at 1°C / min, and heat to -80°C at 10°C / min. After keeping at -80°C for 20 minutes, the cryopreservation solution was transferred to liquid nitrogen for storage for 6 months.
[0042] Cell recovery: Take out the cryopreserved tube and quickly place it in a 37℃ water bath, shake and thaw the cell suspension completely, then dilute it with 5 times the culture medium, centrifuge at 1000 rpm for 5 minutes, remove the supernatant by centrifugation, repeat the experiment 3 times, calculate the cell survival rate, and take the average value. The cell survival rate is calculated by the trypan blue exclusion test. After diluting the cell sediment containing adipose mesenchymal stem cells after centrifugation, take 5μL of the sample to be tested, mix it with 5μL of 0.4% trypan blue solution, and drop it into the cell counting plate after 1 minute. Observe and count under the microscope with CountStar cell counter. Dead cells are stained light blue, and live cells are rejected. The cell survival rate (%) is calculated statistically. Cell survival rate (%) = live cells / (number of live cells + number of dead cells) × 100%. The results are shown in Table 1 below.
[0043] Table 1 Cell viability test results
[0044] According to the results in Table 1, the cryopreservation solutions in Examples 1 to 3 can maintain a cell survival rate of about 98% for adipose-derived mesenchymal stem cells, and Example 4 can maintain a cell survival rate of more than 96% for adipose-derived mesenchymal stem cells. The effects of Examples 1 to 3 are obviously better than those of Example 4. However, compared with the cryopreservation solutions in Comparative Examples 1 to 4, each of the Examples can better protect the internal structure of the cells, reduce the change in the intracellular solute concentration during freezing and thawing, and the cell survival rate is higher.
[0045] It can be seen that the cryopreservation solution provided in the present application scheme can maintain a good cell survival rate of adipose-derived mesenchymal stem cells and has a good cryoprotective effect. However, since the use of dimethyl sulfoxide and the like may cause cytotoxicity to adipose-derived mesenchymal stem cells, the cytotoxicity of the cryopreservation solution still needs to be verified.
[0046] Test Example 2 Growth curve drawing and detection Prepare a 96-well plate and take the thawed P5 adipose-derived mesenchymal stem cell single cell suspension to adjust the cell concentration to about 1×10 6 L -1 , inoculated in a 96-well plate (200 μL / well). Take one specimen from each group every day, add 20 μL 5 mg / L MTT 4 h before terminating the culture, continue to culture for 4 h, add 150 μL DMSO, place at room temperature for 15-20 min, shake the culture plate for 10 min to make the staining uniform, use an enzyme reader to measure the absorbance of each well at a wavelength of 490 nm (A), calculate the mean of each group, and draw a growth curve for 8 consecutive days. The results are shown in the attached figure. Figure 1 shown.
[0047] Attached Figure 1 The results show that the growth curves of the adipose-derived mesenchymal stem cells treated in Examples 1 to 4 have a shorter incubation period than those in Comparative Examples 1 to 4, and the growth effect in the logarithmic growth phase is better, among which Examples 1 to 3 have better effects. It can be seen that the adipose-derived mesenchymal stem cells treated with the cryopreservation solution of Examples 1 to 4 in the present application have better proliferation ability after thawing, and the adipose-derived mesenchymal stem cells still maintain good cell stemness.
[0048] Attached Figure 2 The results show the growth of adipose-derived mesenchymal stem cells in Example 1 and Example 4 at 1d, 2d, 4d and 8d. According to the growth status of adipose-derived mesenchymal stem cells in the figure, when recombinant human albumin produced by Pichia pastoris is used in combination with other components in the cryopreservation solution, the mesenchymal stem cells grow better after thawing than when human serum albumin from a blood source is used, and the effect of freezing on adipose-derived mesenchymal stem cells is smaller.
[0049] Test Example 3: Purification, collection and detection of exosomes The thawed P5 adipose-derived mesenchymal stem cells were cultured in serum-free DMEM / F12 medium for 48 h, the supernatant was collected, centrifuged and concentrated using a 100 kD ultrafiltration tube, EXOquick-TC exosome precipitation reagent was added at a ratio of 5:1 (v:v), and the precipitate was resuspended in PBS after centrifugation to obtain exosomes of adipose-derived mesenchymal stem cells. The protein concentration of exosomes expressed by adipose-derived mesenchymal stem cells was detected using the BCA method. Taking Comparative Example 1 as the control, the relative expression of exosomes is shown in the attached figure. Figure 3 shown.
[0050] According to the attached Figure 3 The results show that the adipose-derived mesenchymal stem cells frozen and thawed in Examples 1 to 4 of the present application can maintain a high exosome secretion capacity, among which Examples 1 to 3 have better effects; it can be seen that the cryopreservation solution provided in the present application has a weaker cytotoxicity to adipose-derived mesenchymal stem cells through the coordination of the components and the adjustment of the dosage.
[0051] Test Example 4 Detection of secreted factors The thawed P5 adipose-derived mesenchymal stem cells were cultured in serum-free DMEM / F12 medium for 96 h, and the culture supernatant was collected by centrifugation. The contents of secretory factors TGF-b, HGF, PGE2, and IL-6 in the supernatant were detected by ELISA. Figure 4 shown.
[0052] According to the attached Figure 4 The results show that the adipose-derived mesenchymal stem cells treated with the cryopreservation solutions of Examples 1 to 4 still maintain a relatively high cytokine secretion capacity and relatively good cell stemness, among which Examples 1 to 3 have better effects, indicating that the effect of using recombinant human albumin in the cryopreservation solution provided in the present application is better than that of hematogenous human serum albumin.
[0053] Experimental Example 1 Comparison between recombinant human albumin and blood-derived human serum albumin The experimenters found that when recombinant human albumin is combined with other components in the present application, it has a better effect as a cell cryopreservation solution for mesenchymal stem cells. Therefore, the structural difference between recombinant human albumin and human serum albumin from blood sources was explored. Specifically, the free thiol content of albumin was detected by DTNB method, and the results are shown in Table 2 below.
[0054] Table 2 Free thiol content of recombinant human albumin and blood-derived human serum albumin
[0055] The experimenters found that the content of free thiol groups in recombinant human albumin is higher than that in blood-derived human serum albumin. They speculated that this may be one of the reasons why the cell cryopreservation fluid prepared with recombinant human albumin is more effective. The thiol group has antioxidant properties and can work with other components to better protect adipose mesenchymal stem cells from oxidative stress damage.
[0056] In addition, if attached Figure 5 As shown, this is the liquid phase diagram of recombinant human albumin. Recombinant human albumin has better uniformity and higher monomer content. Blood-derived human serum albumin has large protein differences due to individual differences among people. The experimenters speculate that this is also one of the reasons why recombinant human albumin is better than blood-derived human serum albumin.
[0057] The above is only the embodiment of the present application, and the protection scope of the present application is not limited by these specific embodiments, but is determined by the claims of the present application. For those skilled in the art, the present application can have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the technical ideas and principles of the present application should be included in the protection scope of the present application.
Claims
1. A cryopreservation solution for adipose-derived mesenchymal stem cells, characterized in that: It is composed of the following ingredients: human serum albumin solution 6~10% v / v, trehalose 2~4% w / v, poloxamer 188 0.1~0.6% w / v, resveratrol 1~2% w / v, glutathione 1~2% w / v, polyvinyl alcohol 4~6% w / v and DMSO 3~4% v / v. Finally, the compound electrolyte injection and compound amino acid injection are supplemented to 100% in a 1:1 ratio.
2. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: The volume concentration of the human serum albumin solution is 20±5%.
3. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 2, characterized in that: The human serum albumin is recombinant human albumin fermented by Pichia pastoris.
4. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: The molecular weight of the polyvinyl alcohol is 12 kDa~15 kDa.
5. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: The compound amino acid injection contains L-proline, L-serine, L-alanine, L-isoleucine, L-leucine, L-aspartic acid, L-tyrosine, L-glutamic acid, L-phenylalanine, L-arginine hydrochloride, L-lysine hydrochloride, L-valine, L-threonine, L-histidine hydrochloride, L-tryptophan, L-methionine, L-cystine, glycine, sorbitol and sodium bisulfite.
6. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 5, characterized in that: Each 1000 mL of the compound amino acid injection contains 1.00 g of L-proline, 1.00 g of L-serine, 2.00 g of L-alanine, 3.52 g of L-isoleucine, 4.90 g of L-leucine, 2.50 g of L-aspartic acid, 0.25 g of L-tyrosine, 0.75 g of L-glutamic acid, 5.33 g of L-phenylalanine, 5.00 g of L-arginine hydrochloride, 4.30 g of L-lysine hydrochloride, 3.60 g of L-valine, 2.50 g of L-threonine, 2.50 g of L-histidine hydrochloride, 0.90 g of L-tryptophan, 2.25 g of L-methionine, 0.10 g of L-cystine, 7.60 g of glycine, 50.00 g of sorbitol and 0.50 g of sodium bisulfite.
7. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: The composite electrolyte solution comprises sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride.
8. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 7, characterized in that: The composite electrolyte solution contains 5.26 g of sodium chloride, 5.02 g of sodium gluconate, 3.68 g of sodium acetate, 0.37 g of potassium chloride and 0.30 g of magnesium chloride per 1000 mL.
9. The adipose-derived mesenchymal stem cell cryopreservation solution according to claim 1, characterized in that: It is composed of the following ingredients: human serum albumin solution 8% v / v, trehalose 3% w / v, poloxamer 188 0.4% w / v, resveratrol 1% w / v, glutathione 1% w / v, polyvinyl alcohol 5% w / v and DMSO 3% v / v, and finally the compound electrolyte injection and compound amino acid injection are supplemented to 100% in a 1:1 ratio.
10. Use of the adipose-derived mesenchymal stem cell cryopreservation solution according to any one of claims 1 to 9 in cryopreservation of adipose-derived mesenchymal stem cells.
Citation Information
Patent Citations
Cryopreservation liquid and injection of mesenchymal stem cells
CN102792947A
Cell cryopreservation fluid
CN105961374A
Clinical mesenchymal stem cell cryopreservation solution and preparation method thereof
CN109329271A
Fat storage liquid and preparation method thereof
CN109497038A
Preserving fluid for adipose tissue-derived stromal cells
CN109526941A
Cited By
Exosome freeze-drying protective agent and exosome preparation
CN119868287A
